Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$112.65$309.34
1-Month Range
Month down -19.1%
$208.00$290.06
Daily Price Range
Day up 2.0%
$216.36$227.71
Volume
vs 3M avg
6967203M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$33.1B
Short % of Float—
Employees—
Sales$4,343M
Shares Outstanding151,200,000
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.ilmn.com
Illumina Inc — Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenat….· via yahoo
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
50
Growth
67
Quality
95
Sentiment
95
Insider Sent.
0
Piotroski F
8
Altman Z
6.3
Consensus rating unavailable — no analyst coverage on file for ILMN.
Price targets unavailable — no 12-month targets on file for ILMN.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on ILMN, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:08 PM UTC